Monday, October 09, 2006

RNAi: Nobel Prize-Winning Biotechnology

RNAi: Nobel Prize-Winning Biotechnology
Drugs based on the technology have a long way to go, but the future does look promising.
THE MOTLEY FOOL


Updated: 7:15 a.m. MT Oct 5, 2006
The Nobel Prize in physiology or medicine was awarded earlier this week. It went to Andrew Fire of Stanford University and Craig Mello of the University of Massachusetts Medical School for their work in RNA interference (RNAi). This technology is relatively young by Nobel standards, with the acknowledged research being completed less than 10 years ago. RNAi works by targeting messenger RNA and preventing it from being translated into protein, thus "knocking down" specific gene products. It is similar to antisense technology developed a decade earlier, but has so far proven more robust and effective.

The biotechnology industry has been quick to recognize and adopt RNAi as a tool in drug development programs, and to explore its potential as a therapeutic entity itself.

More

Phoenix Arizona

0 Comments:

Post a Comment

Links to this post:

Create a Link

<< Home